These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31365924)

  • 21. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant β-Lactam Therapy Combined with Vancomycin or Daptomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis.
    Wang C; Ye C; Liao L; Wang Z; Hu Y; Deng C; Liu L
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32839217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
    Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S;
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on Staphylococcus aureus bacteraemia.
    Tabah A; Laupland KB
    Curr Opin Crit Care; 2022 Oct; 28(5):495-504. PubMed ID: 35942696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of Vancomycin or Daptomycin and Beta-lactam Antibiotics: A Meta-analysis.
    Kale-Pradhan PB; Giuliano C; Jongekrijg A; Rybak MJ
    Pharmacotherapy; 2020 Jul; 40(7):648-658. PubMed ID: 32533859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible
    Chastain DB; Covert KL; Tu PJ; McDougal S; White BP; Cluck D
    Ann Pharmacother; 2023 Nov; 57(11):1312-1327. PubMed ID: 36946576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible
    Kufel WD; Zagoria Z; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Ann Pharmacother; 2024 Apr; 58(4):360-365. PubMed ID: 37542415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Truong J; Veillette JJ; Forland SC
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the Success of Cefazolin plus Ertapenem in Methicillin-Susceptible Staphylococcus aureus Bacteremia Based on Release of Interleukin-1 Beta?
    Smelter D; Hayney M; Sakoulas G; Rose W
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0216621. PubMed ID: 34978891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.
    Cheng MP; Lawandi A; Butler-Laporte G; De l'Étoile-Morel S; Paquette K; Lee TC
    Clin Infect Dis; 2021 May; 72(9):e196-e203. PubMed ID: 32667982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.
    Chan KE; Warren HS; Thadhani RI; Steele DJ; Hymes JL; Maddux FW; Hakim RM
    J Am Soc Nephrol; 2012 Sep; 23(9):1551-9. PubMed ID: 22904350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.
    Davis JS; Sud A; O'Sullivan MVN; Robinson JO; Ferguson PE; Foo H; van Hal SJ; Ralph AP; Howden BP; Binks PM; Kirby A; Tong SYC; ; ; Tong S; Davis J; Binks P; Majumdar S; Ralph A; Baird R; Gordon C; Jeremiah C; Leung G; Brischetto A; Crowe A; Dakh F; Whykes K; Kirkwood M; Sud A; Menon M; Somerville L; Subedi S; Owen S; O'Sullivan M; Liu E; Zhou F; Robinson O; Coombs G; Ferguson P; Ralph A; Liu E; Pollet S; Van Hal S; Foo H; Van Hal S; Davis R
    Clin Infect Dis; 2016 Jan; 62(2):173-180. PubMed ID: 26349552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftaroline for the treatment of methicillin-resistant
    White BP; Barber KE; Stover KR
    Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focusing the Lens on the CAMERA Concepts: Early Combination β-Lactam and Vancomycin Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Wilsey HA; Burgess DR; Burgess DS
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.
    Rose WE; Eickhoff JC; Shukla SK; Pantrangi M; Rooijakkers S; Cosgrove SE; Nizet V; Sakoulas G
    J Infect Dis; 2012 Nov; 206(10):1604-11. PubMed ID: 22966128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ
    Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
    Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus.
    Singh NB; Yim J; Jahanbakhsh S; Sakoulas G; Rybak MJ
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):363-370. PubMed ID: 29807674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.